BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2128982)

  • 21. Scanning electron microscopy of the tegumental surface of in vivo treated Schistosoma mansoni (Saudi Arabian geographical strain) with oxamniquine and praziquantel.
    Shalaby IM; Banaja AA; Ghandour AM
    J Egypt Soc Parasitol; 1991 Dec; 21(3):797-810. PubMed ID: 1765693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity.
    Botros S; Soliman A; el-Gawhary N; Selim M; Guirguis N
    Trans R Soc Trop Med Hyg; 1989; 83(1):86-9. PubMed ID: 2513673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined praziquantel-oxamniquine treatment of schistosomiasis: synergy in low dosage.
    Pugh RN
    Trans R Soc Trop Med Hyg; 1991; 85(5):699. PubMed ID: 1815568
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite.
    Delgado VS; Suárez DP; Cesari IM; Incani RN
    Parasitol Res; 1992; 78(8):648-54. PubMed ID: 1480600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific treatment of advanced schistosomiasis liver disease in man: favourable results.
    Coutinho A; Domingues AL
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():335-40. PubMed ID: 3151109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schistosomiasis update.
    Gilles HM
    Int J Dermatol; 1988; 27(6):400-1. PubMed ID: 3147951
    [No Abstract]   [Full Text] [Related]  

  • 29. Case 4-1996: paralysis due to schistosomiasis.
    Nishioka Sde A
    N Engl J Med; 1996 Jun; 334(23):1548-9. PubMed ID: 8618623
    [No Abstract]   [Full Text] [Related]  

  • 30. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Specific treatment as a weapon for controlling schistosomiasis].
    Bina JC
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():195-202. PubMed ID: 1343895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonographic profile of the liver and caliber of portal vein after oral antibilharzial drugs.
    el-Hawey AM; Wahib AA; Ossman OM; el Zahaby AA
    J Egypt Soc Parasitol; 1989 Dec; 19(2):605-10. PubMed ID: 2504826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.
    Sturrock RF; Bensted-Smith R; Butterworth AE; Dalton PR; Kariuki HC; Koech D; Mugambi M; Ouma JH; arap Siongok TK
    Trans R Soc Trop Med Hyg; 1987; 81(2):303-14. PubMed ID: 3113005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N; Rocha RS
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):310-4. PubMed ID: 6762634
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of 700 cases of bilharziasis with the new drugs oxamniquine, oltipraz, praziquantel].
    Lapierre J; Keita A; Faurant C; Heyer F; Tourte-Schaefer C; Ancelle T; Dupouy-Camet J
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):526-33. PubMed ID: 6673843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
    Lambertucci JR; Modha J; Curtis R; Doenhoff M
    Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis.
    Pugh RN; Teesdale CH
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):877-8. PubMed ID: 6412867
    [No Abstract]   [Full Text] [Related]  

  • 40. A new approach to the treatment of acute schistosomiasis.
    Lambertucci JR
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():23-30. PubMed ID: 2517865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.